Health Care • Medical/Nursing Services
$29.67 ▲ +0.35
(+1.19%)
MKT CAP: $6.92B • VOL: 7.52M
52W L $14 52W H $48
HIMS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.35B | $1.48B | $872.0M |
| YoY Revenue Growth % | +59.0% | +69.3% | — |
| Gross Profit | $1.73B | $1.17B | $383.7M |
| Gross Margin % | 73.8% | 79.5% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $105.6M | $61.9M | -$29.5M |
| Operating Margin % | 4.5% | 4.2% | -3.4% |
| Net Income (GAAP) | $128.4M | $126.0M | -$23.5M |
| EBITDA (Normalized) | $190.1M | $115.1M | $1.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $300.0M | $251.1M | $73.5M |
| Capital Expenditures (CapEx) | $105.6M | $66.4M | $39.2M |
| Free Cash Flow (FCF) | $194.4M | $184.6M | $34.2M |
| FCF Margin % | 8.3% | 12.5% | 3.9% |
| Return on Invested Capital (ROIC %) | 8.0% | 13.6% | -1.0% |
| Cash & Short-Term Equivalents | $228.6M | $220.6M | $418.8M |
| Total Debt (Short + Long Term) | $726.2M | $103.9M | $890.9M |
| Total Stockholders' Equity | $540.9M | $476.7M | $1.83B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HIMS.